RxDoctor Payments DataLook up a doctor →

Wayne Burkhead, MD

Orthopaedic Surgery · Dallas, TXNPI 1073533774

Payments from drug & device makers

$1,159,042in general payments, 2019–2025

Across 159 payments — averaging $7289.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$975K
  • FX Shoulder Solutions, Inc$134K
  • Techmah Medical, LLC$33K
  • Limacorporate S.p.a.$12K
  • Lima USA, Inc.$3K
  • Arthrex$1K
  • plus $873 from 11 others
$7,000in research payments, 2019–2025

Across 6 payments — averaging $1166.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • FX Shoulder Solutions, Inc$7K

What the payments were for

  • Royalty or licence$1,012,63488%
  • Consulting fees$110,25110%
  • Speaking & faculty fees$2,5000%
  • Travel & lodging$22,0152%
  • Food & beverage$5,2310%
  • Education$9620%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,159,042 in reported general payments places this provider in the 95th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$223,737
Medicare patients
395
Services billed
3,698

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Calcitonin-SalmonCalcitonin,salmon,synthetic62$3,373
OxycontinOxycodone Hcl12$810
Gabapentin113$712
Doxycycline Hyclate25$280
Methocarbamol46$257
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen42$236
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen20$188
Tramadol Hcl32$125
Ibuprofen11$78
Meloxicam60$74
Prednisone40$57

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →